← Leaderboards
Omolola Eniola-Adefeso
University Of Michigan At Ann Arbor
$4,722,113
Attributed
$6,324,855
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,324,855 · 6
By mechanism
R01$3,106,370 · 2
U24$2,652,826 · 1
R21$404,933 · 1
R03$147,726 · 1
R13$13,000 · 1
Top collaborators
- Tristan Maerz2 shared
- Timothy Francis Scott2 shared
- Kelly R Stevens2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Christiane Wobus$7,155,858
- Greg Thurber$4,032,895
- Mohammed Akaaboune$6,423,588
- Mark E Meyerhoff$16,191,724
- James R Baker$11,149,531
Others in their field
Top investigators on “Surface”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$207,726,216
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$118,664,913
Research focus
SurfaceIn VivoCharacteristicsPharmaceutical PreparationsParticleTissuesInflammationAffectPolymersBaseBlood VesselsEndotheliumEngineeringDesignSuccessBloodNanoparticleShapesChronicKineticsLeadResolutionAdhesionsExcision
Grant awards (16)
Humanity Unlocking Biomaterials (HUB) Coordinating Center$1,595,179
U24 · FY2025 · EB · contact PI
Humanity Unlocking Biomaterials (HUB) Coordinating Center$1,057,647
U24 · FY2024 · EB · contact PI
Bioerodible corticosteroid microparticle-drug as an intra-articular drug delivery system for osteoarthritis therapy$258,334
R21 · FY2023 · AR
Development of PolyAspirin Particles for Therapeutic Intervention in ALI/ARDS via the Passive Restraint of Neutrophil Function$343,037
R01 · FY2022 · HL · contact PI
Bioerodible corticosteroid microparticle-drug as an intra-articular drug delivery system for osteoarthritis therapy$146,599
R21 · FY2022 · AR · contact PI
Development of PolyAspirin Particles for Therapeutic Intervention in ALI/ARDS via the Passive Restraint of Neutrophil Function$435,387
R01 · FY2021 · HL · contact PI
Development of PolyAspirin Particles for Therapeutic Intervention in ALI/ARDS via the Passive Restraint of Neutrophil Function$466,500
R01 · FY2020 · HL · contact PI
Role of carrier plasma protein corona in their vascular wall localization$397,840
R01 · FY2016 · HL · contact PI
Nanotechnology in Medicine: From Molecules to Humans$13,000
R13 · FY2016 · EB · contact PI
Role of carrier plasma protein corona in their vascular wall localization$358,009
R01 · FY2015 · HL · contact PI
Deformable hydrogel microparticles as delivery vehicles to the vascular wall$73,662
R03 · FY2015 · EB · contact PI
Role of carrier plasma protein corona in their vascular wall localization$34,356
R01 · FY2015 · HL · contact PI
Role of carrier plasma protein corona in their vascular wall localization$357,144
R01 · FY2014 · HL · contact PI
Deformable hydrogel microparticles as delivery vehicles to the vascular wall$74,064
R03 · FY2014 · EB · contact PI
Role of carrier plasma protein corona in their vascular wall localization$347,830
R01 · FY2013 · HL · contact PI
Role of carrier plasma protein corona in their vascular wall localization$366,267
R01 · FY2012 · HL · contact PI